ArticlesEnhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
References (16)
- et al.
Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content
Lancet
(1980) - et al.
Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation
Lancet
(1994) - et al.
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
Lancet
(1993) - et al.
Oral contraceptive use in relation to myocardial infarction
Lancet
(1979) - Whw Inman, Mp Vessey, B. Westerholm, A. Engelund, Thromboembolic disease and the steroidal content of...
contraceptives: a report to the Committee on Safety of Drugs
BMJ
(1970)- et al.
Oral contraceptives and venous thromboembolism: findings in a large prospective study
BMJ
(1986)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1995 Published by Elsevier Ltd.